Tekla Life Sciences Investors
Location
Massachusetts
Founded
2000-01-26
Website
Risk Signals
155 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Management Investment Offices, Open-End), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Tekla Life Sciences Investors
Live alerts from global media, monitored by Business Radar
2023-11-30 (marketbeat.com)
Johnson & Johnson (NYSE:JNJ) Stock Position Raised by Graham Capital Management L.P.
Graham Capital Management L.P. raised its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 108.3% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 108,569 shares of the company's stock after acquiring a
Read more
2023-10-09 (defenseworld.net)
Johnson & Johnson (NYSE:JNJ) Shares Bought by RNC Capital Management LLC
RNC Capital Management LLC raised its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
Read more
2023-09-29 (marketbeat.com)
Lbmc Investment Advisors LLC Acquires 1,287 Shares of Johnson & Johnson (NYSE:JNJ)
Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 21.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,294 shares of the company's stock after purchasing an additional 1,287 s
Read more
2023-09-29 (marketbeat.com)
Lbmc Investment Advisors LLC Acquires 1,287 Shares of Johnson & Johnson (NYSE:JNJ)
Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 21.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,294 shares of the company's stock after purchasing an additional 1,287 s
Read more
2023-09-21 (yahoo.com)
Insider Buying: President Daniel Omstead Acquires 12,000 Shares of Tekla Life Sciences ...
On September 20, 2023, President Daniel Omstead of Tekla Life Sciences Investors (NYSE:HQL) made a significant purchase of 12,000 shares of the company's stock.
Read more
2023-09-21 (yahoo.com)
Insider Buying: President Daniel Omstead Acquires 12,000 Shares of Tekla Life Sciences ...
On September 20, 2023, President Daniel Omstead of Tekla Life Sciences Investors (NYSE:HQL) made a significant purchase of 12,000 shares of the company's stock.
Read more
2023-03-16 (bakersfield.com)
Tekla Life Sciences Investors Announce Renewal of Share Repurchase Program
BOSTON--(BUSINESS WIRE)--Mar 16, 2023--
Read more
2023-03-16 (bakersfield.com)
Tekla Life Sciences Investors Announce Renewal of Share Repurchase Program
BOSTON--(BUSINESS WIRE)--Mar 16, 2023--
Read more
2022-03-22 (teklacap.com)
Tekla Life Sciences Investors Announce Renewal of Share ...
22-03-2022 · BOSTON, MA, March 22, 2022 – Tekla Life Sciences Investors (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program.
Read more
2022-03-22 (valdostadailytimes.com)
Tekla Life Sciences Investors Announce Renewal of Share Repurchase Program
BOSTON--(BUSINESS WIRE)--Mar 22, 2022--
Read more
2021-03-25 (teklacap.com)
Tekla Life Sciences Investors Announce Renewal of Share ...
25-03-2021 · BOSTON, MA, March 25, 2021 – Tekla Life Sciences Investors (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program.
Read more
(morningstar.com)
Tekla Life Sciences Investors Announce Renewal of Share Repurchase Program
Tekla Life Sciences Investors (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July
Read more